Pfizer has been
committed to innovation in hemophilia for over
25 years
Pfizer has a long history of supporting the hemophilia community, and we remain committed to innovation and continued research. While significant progress has been made, we believe even more can be done to improve treatment.
Pfizer is currently working to unlock the potential of gene therapy (transfer or addition) Gene therapy (transfer or addition) The transfer or addition of genetic material into a cell. Once in the cell, a working copy of a gene can help make proteins despite the presence of a faulty or mutated gene. for people living with hemophilia worldwide.
FIND A PAL - Connect With Your Pfizer Patient Affairs Liaison
The Pfizer Patient Affairs Liaisons (PALs) help connect patients living with a rare disease to educational resources: Subscribe | TogetherForRare.com
For additional resources from Pfizer on living with hemophilia, visit HemophiliaVillage.com
Want more information about gene therapy for hemophilia?
Register for updates